PharmaEssentia Corporation (LUX:261280523)
Luxembourg flag Luxembourg · Delayed Price · Currency is EUR · Price in USD
16.90
+0.10 (0.60%)
At close: Oct 21, 2025

PharmaEssentia Revenue

PharmaEssentia had revenue of 3.60B TWD in the quarter ending June 30, 2025, with 56.19% growth. This brings the company's revenue in the last twelve months to 12.63B, up 82.77% year-over-year. In the year 2024, PharmaEssentia had annual revenue of 9.73B with 90.67% growth.

Revenue (ttm)
12.63B TWD
Revenue Growth
+82.77%
P/S Ratio
14.62
Revenue / Employee
96.45M TWD
Employees
131
Market Cap
5.38B EUR

Revenue Chart

* This company reports financials in TWD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20249.73B4.63B90.67%
Dec 31, 20235.11B2.22B77.15%
Dec 31, 20222.88B2.23B339.00%
Dec 31, 2021656.51M99.25M17.81%
Dec 31, 2020557.26M251.57M82.29%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Reinet Investments S.C.A.798.00M
Socfinaf663.01M
Socfinasia199.82M
CPI FIM182.41M
Luxempart97.19M
Fotex Holding S.E.42.87M
Velcan Holdings2.95M
Revenue Rankings